Sponsor or institution
Clinical trials and research at Adlai Nortye Biopharma Co., Ltd.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Adlai Nortye Biopharma Co., Ltd. that are recruiting, at sites in 3 countries (most in United States (2), Australia (2), China (1)). By phase: Phase 1 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| AN4035 in advanced cancers with RAS mutations and high CEACAM5 expression | Phase 1 | Perth and 1 other locations | Recruiting | Jul 7, 2026 |
| AN8025 first-in-human dose exploration in advanced solid tumors | Phase 1 | Nedlands, Western Australia | Recruiting | Jun 10, 2026 |
| Oral AN9025 for advanced solid tumors with RAS mutations | Phase 1 | Orlando, Florida and 2 other locations | Recruiting | Nov 26, 2025 |
| Investigating AN4005 for advanced tumors and lymphoma | Phase 1 | Hackensack, New Jersey and 6 other locations | Recruiting | Aug 10, 2021 |
All recruiting trials (4)
-
AN4035 in advanced cancers with RAS mutations and high CEACAM5 expression
This first-in-human trial tests AN4035 to see if it is safe, tolerable, and possibly active in people with RAS-mutated, CEACAM5-positive advanced solid tumors, including when given with cetuximab.
-
AN8025 first-in-human dose exploration in advanced solid tumors
Researchers are testing different starting doses of AN8025 in adults with advanced solid tumors to see which dose is safe and tolerable and to find the highest dose that can be given safely.
-
Oral AN9025 for advanced solid tumors with RAS mutations
This trial tests whether the oral drug AN9025 is safe and tolerable for adults with advanced solid tumors that have RAS mutations.
-
Investigating AN4005 for advanced tumors and lymphoma
This study is testing a new drug called AN4005 to see if it is safe and how well it works for people with advanced tumors and lymphomas who don't have other treatment options.
Quick answers
How many clinical trials run by Adlai Nortye Biopharma Co., Ltd. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), Australia (2 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.